Work

The role of E3 ubiquitin ligase CBLB in mediating innate immunity to pulmonary infections

Year: 2024
Type: article
Abstract: Pulmonary infections are the leading infectious cause of hospitalizations and mortality in the United States.Pulmonary infections are common in immunocompromised patients due to the constant exposure and reduced resistance to pathogens.It is estimated that 2.7% of Americans, or around 8 million people, are immunocompromised due to HIV/AIDS, chemotherapy, and immunomodulatory medicines.Long-term use of antibiotics for other infections and prophylaxis, frequent hospital stays, corticosteroid use, and low CD4 + T cell counts enhance the risk of pathogens colonizing the airways of immunocompromised patients.When a pathogen reaches the alveoli, macrophages initiate an inflammatory response, which can either control the infection or overwhelm the host's already compromised immune system.Inflammatory processes in the lung parenchyma can impair gaseous exchange, leading to severe infections.The functions of the innate immune cells are controlled by many host factors early in infection.Deciphering the contribution and mechanisms of host factors implicated in different signaling pathways in immune regulation against pulmonary bacterial and fungal infections can help develop effective antimicrobial immunotherapies.Casitas B-lineage lymphoma proto-oncogene-b (CBLB), an E3 ubiquitin ligase, is one of the most important negative regulators of immune activation responsible for peripheral tolerance.CBLB is expressed in all leukocyte subsets that regulate signaling pathways in T cells, NK cells, B cells, and myeloid cells.In most cases, CBLB-deficient immune cells enhance T cell responses, and knockout or homozygous mutations in CBLB spontaneously develop autoimmunity and is associated with type 1 diabetes, Grave's disease, and multiple sclerosis.Interestingly, genetic association studies link CBLB-polymorphisms with autoimmunity in humans.Additionally, the iii increased activation potential of CBLB-deficient cells renders them more potent to fight against malignancies or infections.While the role of CBLB in adaptive immunity has been extensively studied, the role of CBLB in myeloid cells during pulmonary fungal infections is not known.Here, we used Non-Tuberculous Mycobacteria (NTM) and pulmonary blastomycosis as mouse infection models to investigate the role of CBLB in innate immune cells during respiratory fungal infections.In Chapter 2, we address the gap in understanding the role of CBLB in modulating immune responses during pulmonary NTM infections under T-cell deficiency.NTM are ubiquitous environmental bacteria that may cause pathology ranging from chronic lung infections to fatal disseminated disease.The incidence and prevalence of NTM infections are increasing globally, partially due to increased immunocompromised patients.The diagnosis is often misleading, and the recent emergence of multi-drug resistant clinical strains has complicated the treatment of NTM disease.The first line of defense against lung infections is alveolar macrophages.However, in some instances, particularly in immunocompromised conditions, the potency of alveolar macrophages is reduced, which leads to increased lung pathology.CBLB is known to inhibit immune responses via proteasomal degradation of substrate proteins.However, the role of CBLB during Non-Tuberculous Mycobacterial infection is unknown, which encouraged us to define the role of CBLB in regulating innate immune responses following an NTM infection in an immunocompromised mouse model.We observed that loss of CBLB resulted in increased bacterial burden and dissemination following intravenous or intratracheal Mycobacterium avium infections under deficient T-cell responses in mice.At cellular levels, Cblb-deficiency impaired innate immune cells, including NK cells, inflammatory monocytes, and macrophages in vivo.However, Cblb-deficient macrophages were competent to control NTM growth and produced With immense gratitude, I express my appreciation to all those who have supported me throughout my doctoral journey.Completing a PhD is challenging, and I could not have achieved this without the help, moral support, and encouragement of so many people.First and foremost, I would like to express my sincere gratitude to my advisor, Dr. Som Nanjappa, for his unwavering support and guidance throughout my Ph.D. I am indebted to him for his invaluable insights, advice, and feedback that have helped me grow professionally and personally.His mentorship has been valuable to me, and I am grateful for his patience and understanding during the ups and downs of my research.I would also like to thank my dissertation committee members, Dr
Language: English
Subfield: Immunology
Open Access status: green
OpenAlex ID: W7220807173
FWCI:
Cites: 481
Cited by:
Related to: 10